Cargando…

Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models

The world health organization (WHO) estimated that 18 million people are struck by Alzheimer's disease (AD). The USA, France, Germany, and other countries launched major programmes targeting the identification of risk factors, the improvement of caretaking, and fundamental research aiming to po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kramer, Thomas, Schmidt, Boris, Lo Monte, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408674/ https://www.ncbi.nlm.nih.gov/pubmed/22888461 http://dx.doi.org/10.1155/2012/381029

Ejemplares similares

Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site
por: Rippin, Ido, et al.
Publicado: (2020)

9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells
por: Poloznikov, Andrey, et al.
Publicado: (2021)

Promotion of natural tooth repair by small molecule GSK3 antagonists
por: Neves, Vitor C. M., et al.
Publicado: (2017)

Cell cycle reactivation of cochlear progenitor cells in neonatal FUCCI mice by a GSK3 small molecule inhibitor
por: Roccio, M., et al.
Publicado: (2015)

Small Molecule GSK-3 Inhibitors Safely Promote the Proliferation and Viability of Human Dental Pulp Stem Cells—In Vitro
por: Hanna, Samer, et al.
Publicado: (2023)

Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease
por: Shri, Suggala Ramya, et al.
Publicado: (2023)

The GSK3 hypothesis of Alzheimer's disease
por: Hooper, Claudie, et al.
Publicado: (2008)

GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice
por: Pearce, Andrew C., et al.
Publicado: (2021)

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer
por: Kuroki, Hiroo, et al.
Publicado: (2019)

Structural insight into small molecule action on Frizzleds
por: Kozielewicz, Paweł, et al.
Publicado: (2020)

GSK3 and Alzheimer’s Disease: Facts and Fiction…
por: Kremer, Anna, et al.
Publicado: (2011)

GSK-3 and lysosomes meet in Alzheimer’s disease
por: Avrahami, Limor, et al.
Publicado: (2013)

Small molecule inhibitors of mammalian GSK-3β promote in vitro plant cell reprogramming and somatic embryogenesis in crop and forest species
por: Berenguer, Eduardo, et al.
Publicado: (2021)

Modeling structure–activity relationships with machine learning to identify GSK3-targeted small molecules as potential COVID-19 therapeutics
por: Pirzada, Rameez Hassan, et al.
Publicado: (2023)

Structural insights into TRPV2 activation by small molecules
por: Pumroy, Ruth A., et al.
Publicado: (2022)

Small-Molecule Inhibitors of Dengue-Virus Entry
por: Schmidt, Aaron G., et al.
Publicado: (2012)

High Throughput FISH Screening Identifies Small Molecules That Modulate Oncogenic lncRNA MALAT1 via GSK3B and hnRNPs
por: Zablowsky, Nina, et al.
Publicado: (2023)

GSK-3 inhibitors induce chromosome instability
por: Tighe, Anthony, et al.
Publicado: (2007)

GSK3 and p53 - is there a link in Alzheimer's disease?
por: Proctor, Carole J, et al.
Publicado: (2010)

GSK-3β, a pivotal kinase in Alzheimer disease
por: Llorens-Marítin, María, et al.
Publicado: (2014)

GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
por: Toral-Rios, Danira, et al.
Publicado: (2020)

GSK-3 and Tau: A Key Duet in Alzheimer’s Disease
por: Sayas, Carmen Laura, et al.
Publicado: (2021)

Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer
por: Kim, Jong Hyun, et al.
Publicado: (2022)

Structural Plasticity of Dendritic Spines Requires GSK3α and GSK3β
por: Cymerman, Iwona A., et al.
Publicado: (2015)

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
por: Augello, Giuseppa, et al.
Publicado: (2020)

Structure-Based Discovery of Small Molecule Inhibitors of Cariogenic Virulence
por: Zhang, Qiong, et al.
Publicado: (2017)

Small Molecule Allosteric Inhibitors of BAX
por: Garner, Thomas P., et al.
Publicado: (2019)

Correction: Small-Molecule Inhibitors of Dengue-Virus Entry
por: Schmidt, Aaron G., et al.
Publicado: (2019)

Inhibition of GSK3 by lithium, from single molecules to signaling networks
por: Freland, Laure, et al.
Publicado: (2012)

Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective Inhibitors
por: Amaral, Brenda, et al.
Publicado: (2023)

Determinants of TRPV4 Activity following Selective Activation by Small Molecule Agonist GSK1016790A
por: Jin, Min, et al.
Publicado: (2011)

Structural insights into selective small molecule activation of PKG1α
por: Metwally, Essam, et al.
Publicado: (2023)

Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158
por: Grobben, Yvonne, et al.
Publicado: (2019)

Targeting Alzheimer’s Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies
por: Tong, Ming, et al.
Publicado: (2016)

Extending the applicability of P3D for structure determination of small molecules
por: Ibáñez de Opakua, Alain, et al.
Publicado: (2021)

Small molecule inhibitors of mesotrypsin from a structure-based docking screen
por: Kayode, Olumide, et al.
Publicado: (2017)

Small-molecule drugs development for Alzheimer's disease
por: Yao, Weiwei, et al.
Publicado: (2022)

Multi-faceted small molecule for Alzheimer’s disease
por: Park, Min Hee, et al.
Publicado: (2023)

Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
por: Dominy, Stephen S., et al.
Publicado: (2019)

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
por: Eldar-Finkelman, Hagit, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_72hgt2tl23iiolvd4neu8nco8q